Key Findings
The North America biosurgery market is evaluated to register a CAGR of 5.60% over the estimated years of 2021 to 2028. The regional market’s growth is accredited to the increased funding and investment by the government, the rising prevalence of chronic conditions like cancer and cardiovascular diseases, the aging population’s prevalence, as well as the rapid acceptance of technological advancements.

Market Insights
The North America biosurgery market growth analysis includes the evaluation of Canada and the United States. Canada’s biosurgery market is anticipated to record a growing trend on account of the increasing number of chronic conditions, the rising surgical procedures, and the growing senior populace. As per the Canadian Institute for Health Information 2020 report, more than 75,000 knee replacements, as well as over 62,000 hip replacements, were performed in the country between 2018 and 2019. These figures indicate an increase of 22.5% and 20.1%, respectively, over the last five years.
In addition, joint replacements have also amplified, with more than 137,000 surgical procedures performed annually, estimated at $1.4 billion for inpatient hospital and physician expenses, excluding rehabilitation. These statistics signify that the demand for biosurgery products is set to increase in Canada. Conversely, heart disease is the second-leading cause of death in the country following cancer. The condition’s high incidence has augmented the need for surgical procedures for cardiac patients, predominantly owing to elevated mortality rates. As a result, these factors are expected to facilitate the North America biosurgery market growth during the forecast years.

Competitive Insights
Some of the major companies operating in the market are Baxter International Inc, Ethicon Inc (Johnson & Johnson), RTI Surgical, etc.
Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments